Case Report: Pathological Complete Response in a Brain-Metastatic Lung Squamous Cell Carcinoma Patient With Long-Term Benefit From Chemo-Immunotherapy

Immune checkpoint inhibitors have brought long-term survival benefit in advanced non-small cell lung cancer patients without driver gene mutations. Even after withdrawal of immunotherapy for a maximum of two years, some patients still benefit from this therapy and the reason is not fully clear. Resu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Chen, Ma, Qiang, Li, Nengsheng, Luo, Nuo, Hao, Shuai, Jiang, Minrui, Pang, Fei, Yang, Yan, Li, Li, He, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504157/
https://www.ncbi.nlm.nih.gov/pubmed/34646760
http://dx.doi.org/10.3389/fonc.2021.693704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504157/
https://www.ncbi.nlm.nih.gov/pubmed/34646760
http://dx.doi.org/10.3389/fonc.2021.693704

Ejemplares similares